Absolute Measurement of Cardiac Injury-Induced microRNAs in Biofluids across Multiple Test Sites. (7th September 2016)

• Record Type: Journal Article
• Authors: Thompson, Karol L.; Boitier, Eric; Chen, Tao; Couttet, Philippe; Ellinger-Ziegelbauer, Heidrun; Goetschy, Manuela; Guillemain, Gregory; Kanki, Masayuki; Kelsall, Janet; Mariet, Claire; de La Moureyre–Spire, Catherine; Mouritzen, Peter; Nassirpour, Rounak; O'Lone, Raegan; Pine, P. Scott; Rosenzweig, Barry A.; Sharapova, Tatiana; Smith, Aaron; Uchiyama, Hidefumi; Yan, Jian; Yuen, Peter S.; Wolfinger, Russ
• Is Part Of: Toxicological sciences. Volume 154:Number 1(2016:Nov.)
• Page Start: 115
• Page End: 125
• Publication Date: 2016-09-07
• Subjects: interlaboratory -- microRNA -- variance -- biomarker; Toxicology -- Periodicals; Toxicology -- Periodicals; Toxicology; Periodicals; 615.9
• DOI: 10.1093/toxsci/kfw143
• Languages: English
• ISSNs: 1096-6080

Abstract

Abstract: Extracellular microRNAs (miRNAs) represent a promising new source of toxicity biomarkers that are sensitive indicators of site of tissue injury. In order to establish reliable approaches for use in biomarker validation studies, the HESI technical committee on genomics initiated a multi-site study to assess sources of variance associated with quantitating levels of cardiac injury induced miRNAs in biofluids using RT-qPCR. Samples were generated at a central site using a model of acute cardiac injury induced in male Wistar rats by 0.5 mg/kg isoproterenol. Biofluid samples were sent to 11 sites for measurement of 3 cardiac enriched miRNAs (miR-1-3p, miR-208a-3p, and miR-499-5p) and 1 miRNA abundant in blood (miR-16-5p) or urine (miR-192-5p) by absolute quantification using calibration curves of synthetic miRNAs. The samples included serum and plasma prepared from blood collected at 4 h, urine collected from 6 to 24 h, and plasma prepared from blood collected at 24 h post subcutaneous injection. A 3 parameter logistic model was utilized to fit the calibration curve data and estimate levels of miRNAs in biofluid samples by inverse prediction. Most sites observed increased circulating levels of miR-1-3p and miR-208a-3p at 4 and 24 h after isoproterenol treatment, with no difference seen between serum and plasma. The biological differences in miRNA levels and sample type dominated as sources of variance, along with outlying performance by a few sites. The standard protocol established in this study was successfully implemented across multiple sites and provides a benchmark method for further improvements in quantitative assays for circulating miRNAs.